Cyp3a44 Inhibitors
Cyp3a44 inhibitors are a class of chemical compounds specifically designed to target and inhibit the activity of the Cyp3a44 enzyme, a member of the cytochrome P450 superfamily. The Cyp3a44 enzyme plays a crucial role in the oxidative metabolism of a wide range of substrates, including endogenous molecules such as hormones, steroids, and fatty acids, as well as exogenous compounds like pharmaceuticals and environmental toxins. As a cytochrome P450 enzyme, Cyp3a44 functions by catalyzing the monooxygenation of its substrates, a biochemical process that involves the incorporation of an oxygen atom into the substrate molecule. This oxidative modification typically enhances the solubility of the substrates, facilitating their subsequent metabolism, conjugation, or excretion. Cyp3a44 is particularly active in the liver, where it contributes to the detoxification processes and the regulation of metabolic pathways that are essential for maintaining homeostasis and protecting the organism from harmful compounds.
Inhibitors of Cyp3a44 are typically small molecules that are designed to bind specifically to the enzyme's active site, effectively blocking its ability to catalyze the oxidation of its natural substrates. These inhibitors may function by occupying the substrate-binding pocket, thereby preventing the substrates from accessing the catalytic core, or by inducing conformational changes that reduce the enzyme's catalytic efficiency. The development of Cyp3a44 inhibitors involves a thorough understanding of the enzyme's three-dimensional structure, particularly the regions involved in substrate recognition and catalysis. By inhibiting Cyp3a44, researchers can explore the enzyme's specific role in various metabolic processes and understand how its inhibition impacts the broader network of cytochrome P450-mediated reactions. The study of Cyp3a44 inhibitors is crucial for elucidating the enzyme's substrate specificity, its interactions with other metabolic enzymes, and its overall contribution to the detoxification and metabolism of a wide array of chemical entities within biological systems. This research enhances our understanding of the diverse functions of cytochrome P450 enzymes and underscores their importance in maintaining the balance of metabolic processes that are vital for cellular and systemic health.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ketoconazole | 65277-42-1 | sc-200496 sc-200496A | 50 mg 500 mg | $62.00 $260.00 | 21 | |
Broad-spectrum antifungal agent acting as a direct inhibitor of Cyp3a44. By inhibiting monooxygenase activity, it directly hinders the target protein within the endoplasmic reticulum membrane, impacting caffeine oxidase and iron ion binding activities. | ||||||
Fluconazole | 86386-73-4 | sc-205698 sc-205698A | 500 mg 1 g | $53.00 $84.00 | 14 | |
Azole antifungal compound acting as a direct inhibitor of Cyp3a44. By specifically suppressing monooxygenase activity, it directly inhibits the target protein within the endoplasmic reticulum membrane, impacting caffeine oxidase and iron ion binding activities. | ||||||
Clotrimazole | 23593-75-1 | sc-3583 sc-3583A | 100 mg 1 g | $41.00 $56.00 | 6 | |
Imidazole antifungal compound known to directly inhibit Cyp3a44. By inhibiting monooxygenase activity, it directly hinders the target protein within the endoplasmic reticulum membrane, impacting caffeine oxidase and iron ion binding activities. | ||||||
Itraconazole | 84625-61-6 | sc-205724 sc-205724A | 50 mg 100 mg | $76.00 $139.00 | 23 | |
Triazole antifungal agent acting as a direct inhibitor of Cyp3a44. By inhibiting monooxygenase activity, it directly hinders the target protein within the endoplasmic reticulum membrane, impacting caffeine oxidase and iron ion binding activities. | ||||||
Miconazole | 22916-47-8 | sc-204806 sc-204806A | 1 g 5 g | $65.00 $157.00 | 2 | |
Imidazole antifungal compound acting as a direct inhibitor of Cyp3a44. By inhibiting monooxygenase activity, it directly hinders the target protein within the endoplasmic reticulum membrane, impacting caffeine oxidase and iron ion binding activities. | ||||||
Terbinafine | 91161-71-6 | sc-338609 | 100 mg | $560.00 | 1 | |
Antifungal agent in research known to directly inhibit Cyp3a44. By suppressing monooxygenase activity, it directly hinders the target protein within the endoplasmic reticulum membrane, impacting caffeine oxidase and iron ion binding activities. | ||||||
Fluoxetine | 54910-89-3 | sc-279166 | 500 mg | $312.00 | 9 | |
Selective serotonin reuptake inhibitor (SSRI) acting as an indirect inhibitor of Cyp3a44. By influencing the oxidative demethylation process, it indirectly impacts monooxygenase activity and inhibits the target protein within the endoplasmic reticulum membrane, affecting caffeine oxidase and iron ion binding activities. | ||||||
Cimetidine | 51481-61-9 | sc-202996 sc-202996A | 5 g 10 g | $62.00 $86.00 | 1 | |
Histamine H2 receptor antagonist acting as an indirect inhibitor of Cyp3a44. By influencing the oxidative demethylation process, it indirectly impacts monooxygenase activity and inhibits the target protein within the endoplasmic reticulum membrane, affecting caffeine oxidase and iron ion binding activities. | ||||||
Ranitidine | 66357-35-5 | sc-203679 | 1 g | $189.00 | ||
Histamine H2 receptor antagonist known to indirectly inhibit Cyp3a44. By influencing the oxidative demethylation process, it indirectly impacts monooxygenase activity and inhibits the target protein within the endoplasmic reticulum membrane, affecting caffeine oxidase and iron ion binding activities. | ||||||
Gemfibrozil | 25812-30-0 | sc-204764 sc-204764A | 5 g 25 g | $65.00 $262.00 | 2 | |
Fibrate agent in research acting as an indirect inhibitor of Cyp3a44. By influencing the steroid metabolic process, it indirectly impacts monooxygenase activity and inhibits the target protein within the endoplasmic reticulum membrane, affecting caffeine oxidase and iron ion binding activities. | ||||||